Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) just unveiled an announcement.
Shandong Boan Biotechnology Co., Ltd. has announced that its board of directors will meet on March 27, 2025, to approve the company’s annual results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting is significant as it will provide insights into the company’s financial health and potential shareholder returns, impacting its market positioning and stakeholder interests.
More about Shandong Boan Biotechnology Company., Limited. Class H
Shandong Boan Biotechnology Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on the biotechnology industry. The company is involved in the development and commercialization of biotechnological products and services.
YTD Price Performance: -6.65%
Average Trading Volume: 208,355
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$4.66B
See more data about 6955 stock on TipRanks’ Stock Analysis page.